Reviews on Biomarker Studies in Aging and Anti-Aging Research

ISBN-13: 9783030256524 / Angielski / Miękka / 2020 / 274 str.

Opis

Using both epidemiological and model organism approaches, we have gained new insights into the physiological and molecular aspects of aging, which has led to significant advancements in potential anti-aging strategies. Reviews on Biomarker Studies in Aging and Anti-Aging Research presents a series of reviews in various aspects of aging and age-related disease research along with several methods which have shown progress as potential anti-aging approaches. The book is aimed at researchers in the areas of aging and chronic disease, as well as to clinical scientists, physicians and major drug companies. It provides important information on disease mechanisms, and each chapter is presented in the context of the aging process, specific chronic diseases or different therapeutic areas.

Spis treści

Of Mice, Whales, Jellyfish and Men: In Pursuit of Increased Longevity.- Effects on Glial Cell Glycolysis in Schizophrenia: an Advanced Aging Phenotype?.- Aging Biomarkers and Novel Targets for Anti-Aging Interventions.- Sex Differences in Aging and Associated Biomarkers.- The Therapeutic Potential of Ketogenic Diet Throughout Life: Focus on Metabolic, Neurodevelopmental and Neurodegenerative Disorders.- Coenzyme Q10 Supplementation in Fibrosis and Aging.- Dietary Restriction, Cardiovascular Aging and Age-related Cardiovascular Diseases: A Review of the Evidence.- Gut Microbiota and Microbiota-Related Metabolites as Possible Biomarkers of Cognitive Aging.- The Impact of Herbal Products in the Prevention, Regeneration and Delay of Skin Aging.- Epigenetic Clock: Just a Convenient Marker or an Active Driver of Aging?.- From White to Brown – Adipose Tissue is Critical to the Extended Lifespan and Healthspan of Growth Hormone Mutant Mice.- The Cytoskeleton as a Modulator of Aging and Neurodegeneration.- Metabolic Biomarkers in Aging and Anti-Aging Research.

O autorze

Dr Paul C. Guest, Ph.D, is a scientific researcher/writer with 35 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease.